Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.32 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.32 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26458014 | 1.00 | ADORA3 (0.32) | ADORA3ALOX15TSHRADORA2AADORA2B | |
| SCHEMBL26457996 | 0.99 | MEN1 (0.33) | ADORA3ALOX15TSHRADORA2AADORA2B | |
| SCHEMBL26457995 | 0.98 | ADORA3 (0.31) | ADORA3ALOX15TSHRADORA2AADORA2B | |
| SCHEMBL22216531 | 0.98 | ADORA3 (0.31) | ADORA3ALOX15TSHRADORA2AADORA2B | |
| SCHEMBL26458097 | 0.98 | ADORA3 (0.31) | ADORA3ALOX15TSHRADORA2AADORA2B | |
| SCHEMBL22216523 | 0.98 | ADORA3 (0.32) | ADORA3ALOX15TSHRADORA2AADORA2B | |
| SCHEMBL22216695 | 0.98 | ADORA3 (0.32) | ADORA3ALOX15TSHRADORA2AADORA2B | |
| SCHEMBL21426328 | 0.98 | ADORA3 (0.32) | ADORA3ALOX15TSHRADORA2AADORA2B | |
| SCHEMBL26458046 | 0.98 | ADORA3 (0.32) | ADORA3ALOX15TSHRADORA2AADORA2B | |
| SCHEMBL22216765 | 0.97 | PDK2 (0.31) | ADORA3ALOX15TSHRADORA2AADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11641778-B2 | Compound and organic light emitting device comprising same | LG CHEM, LTD. (KR) | 2023-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11641778-B2 | Compound and organic light emitting device comprising same | CRY1, CYP1A1, CRY2 | ADORA3 3450/4885ALOX15 253/4885TSHR 4342/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.